These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

489 related items for PubMed ID: 4962311

  • 1. [Results of cytostatic therapy of malignant hemoblastoses].
    Stacher A.
    Wien Z Inn Med; 1966 Jan; 47(1):1-16. PubMed ID: 4962311
    [No Abstract] [Full Text] [Related]

  • 2. [Secondary tumors in hemoblastoses during cytostatic treatment].
    Hartwich G, Butzler W.
    Med Klin; 1971 Oct 22; 66(43):1445-50. PubMed ID: 5001553
    [No Abstract] [Full Text] [Related]

  • 3. [What is reliable in the therapy of hematologic diseases? I. Hemoblastosis and malignant lymphoproliferative diseases].
    Havemann K, Schmidt M, Malchow H, Sodomann CP.
    Internist (Berl); 1970 Dec 22; 11(12):441-9. PubMed ID: 4993105
    [No Abstract] [Full Text] [Related]

  • 4. [On the effect of a cytostatic of the methylhydrazine group on malignant hemoblastomas].
    Böhnel J, Stacher A.
    Wien Med Wochenschr; 1966 May 21; 116(21):468-71. PubMed ID: 4863533
    [No Abstract] [Full Text] [Related]

  • 5. [The treatment of hemoblastoses and malignant lymphomas. Neoplasms of the lymphoreticular tissue, plasmacytoma and Waldenström's disease. (II)].
    Löffler H, Schultis K.
    Med Welt; 1968 Feb 10; 6():393-6. PubMed ID: 4977038
    [No Abstract] [Full Text] [Related]

  • 6. Chemotherapy of the lymphomas.
    Lacher MJ.
    Med Times; 1970 May 10; 98(5):96-102. PubMed ID: 4911076
    [No Abstract] [Full Text] [Related]

  • 7. [Therapy of hemoblastosis. I. Elements of cytostatic and symptomatic therapy].
    Danieli G.
    G Clin Med; 1966 Aug 10; 47(8):732-68. PubMed ID: 4865460
    [No Abstract] [Full Text] [Related]

  • 8. Trenimon treatment in chronic hemoblastoses.
    Quattrin N, Dini E, Montuori R.
    Acta Genet Med Gemellol (Roma); 1968 Jan 10; 17(1):145-52. PubMed ID: 4968994
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Vinblastine treatment of malignant lymphomas.
    Klener P, Donner L, Neuwirtová R, Ort J.
    Neoplasma; 1971 Jan 10; 18(5):505-11. PubMed ID: 4940935
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Malignant lymphoma: individualized treatment according to biological and clinical risk factors].
    Dreyling M.
    Dtsch Med Wochenschr; 2011 Apr 10; 136(14):687-90. PubMed ID: 21448827
    [No Abstract] [Full Text] [Related]

  • 16. Present management of the lymphomas.
    Kabakow B.
    Proc Rudolf Virchow Med Soc City N Y; 2011 Apr 10; 28():39-45. PubMed ID: 4950557
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.